Insider · CIK 0001339976

MacPhee John A

Reports to the SEC for 2 companies · WOODCLIFF LAKE, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001339976

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2021-11-24	Adamas Pharmaceuticals IncU Disposition from Tender	Director	UDisposition from Tender	−202K sh	—	—	0
2021-11-24	Adamas Pharmaceuticals IncStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−24K sh	—	—	0
2021-11-24	Adamas Pharmaceuticals IncStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0
2021-11-24	Adamas Pharmaceuticals IncStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0
2021-11-24	Adamas Pharmaceuticals IncStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0
2021-06-02	Adamas Pharmaceuticals IncA Award	Director	AAward	+5,000 sh	—	—	202,000
2021-06-02	Adamas Pharmaceuticals IncStock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2021-03-12	Adamas Pharmaceuticals IncM Exercise/Conversion	Director	MExercise/Conversion	+192K sh	$0.67	+$128K	197,000
2021-03-12	Adamas Pharmaceuticals IncStock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−192K sh	—	—	0
2020-06-03	Adamas Pharmaceuticals IncA Award	Director	AAward	+5,000 sh	—	—	5,000
2020-06-03	Adamas Pharmaceuticals IncStock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2019-06-05	Adamas Pharmaceuticals IncStock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2018-06-06	Adamas Pharmaceuticals IncStock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2017-06-01	Adamas Pharmaceuticals IncStock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2016-08-05	Adamas Pharmaceuticals IncStock Option (Right to Buy)A Award	Director	AAward	+12.6K sh	—	—	12,600
2016-06-03	Adamas Pharmaceuticals IncStock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2015-05-14	Adamas Pharmaceuticals IncStock Option (Right to Buy)A Award	Director	AAward	+21K sh	—	—	21,000
2011-01-11	PAR PHARMACEUTICAL COMPANIES, INC.A Award	EVP, Pres-Strativa	AAward	+21.6K sh	—	—	124,909
2011-01-11	PAR PHARMACEUTICAL COMPANIES, INC.F Tax Payment	EVP, Pres-Strativa	FTax Payment	−19K sh	$35.98	−$684K	105,903
2011-01-04	PAR PHARMACEUTICAL COMPANIES, INC.F Tax Payment	EVP, Pres-Strativa	FTax Payment	−1,100 sh	$39.79	−$43.8K	103,306
2010-12-20	PAR PHARMACEUTICAL COMPANIES, INC.F Tax Payment	EVP, Pres-Strativa	FTax Payment	−2,347 sh	$38.26	−$89.8K	104,406
2010-11-18	PAR PHARMACEUTICAL COMPANIES, INC.F Tax Payment	EVP, Pres-Strativa	FTax Payment	−13K sh	$37.72	−$492K	105,989
2010-03-22	PAR PHARMACEUTICAL COMPANIES, INC.F Tax Payment	EVP, Pres-Strativa	FTax Payment	−1,732 sh	$25.09	−$43.5K	119,032
2010-03-09	PAR PHARMACEUTICAL COMPANIES, INC.S Sale	EVP, Pres-Strativa	SSale	−3,229 sh	$25.03	−$80.8K	120,764
2010-03-09	PAR PHARMACEUTICAL COMPANIES, INC.S Sale	EVP, Pres-Strativa	SSale	−800 sh	$24.87	−$19.9K	159,804
2010-03-09	PAR PHARMACEUTICAL COMPANIES, INC.S Sale	EVP, Pres-Strativa	SSale	−200 sh	$24.88	−$4,976	159,604
2010-03-09	PAR PHARMACEUTICAL COMPANIES, INC.S Sale	EVP, Pres-Strativa	SSale	−300 sh	$24.89	−$7,467	159,304
2010-03-09	PAR PHARMACEUTICAL COMPANIES, INC.S Sale	EVP, Pres-Strativa	SSale	−700 sh	$24.91	−$17.4K	158,604
2010-03-09	PAR PHARMACEUTICAL COMPANIES, INC.S Sale	EVP, Pres-Strativa	SSale	−200 sh	$24.92	−$4,984	158,404
2010-03-09	PAR PHARMACEUTICAL COMPANIES, INC.S Sale	EVP, Pres-Strativa	SSale	−200 sh	$24.93	−$4,986	158,204
2010-03-09	PAR PHARMACEUTICAL COMPANIES, INC.S Sale	EVP, Pres-Strativa	SSale	−200 sh	$24.94	−$4,988	158,004
2010-03-09	PAR PHARMACEUTICAL COMPANIES, INC.S Sale	EVP, Pres-Strativa	SSale	−1,100 sh	$24.95	−$27.4K	156,904
2010-03-09	PAR PHARMACEUTICAL COMPANIES, INC.S Sale	EVP, Pres-Strativa	SSale	−900 sh	$24.96	−$22.5K	156,004
2010-03-09	PAR PHARMACEUTICAL COMPANIES, INC.S Sale	EVP, Pres-Strativa	SSale	−2,400 sh	$24.97	−$59.9K	153,604
2010-03-09	PAR PHARMACEUTICAL COMPANIES, INC.S Sale	EVP, Pres-Strativa	SSale	−1,578 sh	$24.98	−$39.4K	152,026
2010-03-09	PAR PHARMACEUTICAL COMPANIES, INC.S Sale	EVP, Pres-Strativa	SSale	−3,409 sh	$24.99	−$85.2K	148,617
2010-03-09	PAR PHARMACEUTICAL COMPANIES, INC.S Sale	EVP, Pres-Strativa	SSale	−100 sh	$25.00	−$2,499.5	148,517
2010-03-09	PAR PHARMACEUTICAL COMPANIES, INC.S Sale	EVP, Pres-Strativa	SSale	−3,129 sh	$25.00	−$78.2K	145,388
2010-03-09	PAR PHARMACEUTICAL COMPANIES, INC.S Sale	EVP, Pres-Strativa	SSale	−2,800 sh	$25.01	−$70K	142,588
2010-03-09	PAR PHARMACEUTICAL COMPANIES, INC.S Sale	EVP, Pres-Strativa	SSale	−200 sh	$25.02	−$5,003	142,388
2010-03-09	PAR PHARMACEUTICAL COMPANIES, INC.S Sale	EVP, Pres-Strativa	SSale	−3,802 sh	$25.02	−$95.1K	138,586
2010-03-09	PAR PHARMACEUTICAL COMPANIES, INC.S Sale	EVP, Pres-Strativa	SSale	−3,299 sh	$25.03	−$82.6K	135,357
2010-03-09	PAR PHARMACEUTICAL COMPANIES, INC.S Sale	EVP, Pres-Strativa	SSale	−100 sh	$25.04	−$2,503.5	135,257
2010-03-09	PAR PHARMACEUTICAL COMPANIES, INC.S Sale	EVP, Pres-Strativa	SSale	−3,171 sh	$25.04	−$79.4K	132,086
2010-03-09	PAR PHARMACEUTICAL COMPANIES, INC.S Sale	EVP, Pres-Strativa	SSale	−7,582 sh	$25.05	−$190K	124,504
2010-03-09	PAR PHARMACEUTICAL COMPANIES, INC.S Sale	EVP, Pres-Strativa	SSale	−1,935 sh	$25.06	−$48.5K	122,569
2010-03-09	PAR PHARMACEUTICAL COMPANIES, INC.S Sale	EVP, Pres-Strativa	SSale	−1,205 sh	$25.07	−$30.2K	121,364
2010-03-09	PAR PHARMACEUTICAL COMPANIES, INC.S Sale	EVP, Pres-Strativa	SSale	−400 sh	$25.08	−$10K	120,964
2010-03-09	PAR PHARMACEUTICAL COMPANIES, INC.S Sale	EVP, Pres-Strativa	SSale	−100 sh	$25.09	−$2,509	120,864
2010-03-09	PAR PHARMACEUTICAL COMPANIES, INC.S Sale	EVP, Pres-Strativa	SSale	−100 sh	$25.10	−$2,510	120,764

Recent filings

Accepted (ET)
Nov 244
MacPhee John A0001328143-21-000086
SEC(opens sec.gov)
Jun 44
MacPhee John A0001328143-21-000058
SEC(opens sec.gov)
Mar 164
MacPhee John A0001209191-21-020946
SEC(opens sec.gov)
Jun 54
MacPhee John A0001209191-20-034779
SEC(opens sec.gov)
Jun 64
MacPhee John A0001209191-19-035064
SEC(opens sec.gov)
Jun 74
MacPhee John A0001209191-18-036428
SEC(opens sec.gov)
Jun 24
Adamas Pharmaceuticals Inc0001209191-17-037336
SEC(opens sec.gov)
Aug 84
Adamas Pharmaceuticals Inc0001209191-16-135934
SEC(opens sec.gov)
Jun 74
Adamas Pharmaceuticals Inc0001209191-16-126313
SEC(opens sec.gov)
May 184
Adamas Pharmaceuticals Inc0001209191-15-043873
SEC(opens sec.gov)
Jan 134
MacPhee John A0000878088-11-000024
SEC(opens sec.gov)
Jan 64
MacPhee John A0000878088-11-000004
SEC(opens sec.gov)

Companies

Address

C/O PAR PHARMACEUTICAL COMPANIES, INC. 300 TICE BOULEVARD

WOODCLIFF LAKE, NJ, 07677